Sigma oscillations protect or reinstate motor memory depending on their temporal coordination with slow waves
Abstract
Targeted memory reactivation (TMR) during post-learning sleep is known to enhance motor memory consolidation but the underlying neurophysiological processes remain unclear. Here, we confirm the beneficial effect of auditory TMR on motor performance. At the neural level, TMR enhanced slow wave (SW) characteristics. Additionally, greater TMR-related phase-amplitude coupling between slow (0.5-2 Hz) and sigma (12-16 Hz) oscillations after the SW peak was related to higher TMR effect on performance. Importantly, sounds that were not associated to learning strengthened SW-sigma coupling at the SW trough. Moreover, the increase in sigma power nested in the trough of the potential evoked by the unassociated sounds was related to the TMR benefit. Altogether, our data suggest that, depending on their precise temporal coordination during post learning sleep, slow and sigma oscillations play a crucial role in either memory reinstatement or protection against irrelevant information; two processes that critically contribute to motor memory consolidation.
Data availability
All data can be found at https://zenodo.org/record/6642860#.YqoI46hBzD5. The source code is available at https://github.com/judithnicolas/MotorMemory_OpenLoop_TMR
Article and author information
Author details
Funding
Fonds Wetenschappelijk Onderzoek (G0D7918N)
- Judith Nicolas
- Bradley R King
- David Levesque
- Latifa Lazzouni
- Stephan Swinnen
- Julien Doyon
- Julie Carrier
- Genevieve Albouy
Fonds de Recherche du Québec - Santé (RRQNT-2018-264146)
- Judith Nicolas
- Bradley R King
- David Levesque
- Latifa Lazzouni
- Stephan Swinnen
- Julien Doyon
- Julie Carrier
- Genevieve Albouy
Fonds Wetenschappelijk Onderzoek (G0B1419N)
- Genevieve Albouy
Fonds Wetenschappelijk Onderzoek (G099516N)
- Genevieve Albouy
Fonds Wetenschappelijk Onderzoek (1524218N)
- Genevieve Albouy
Fonds Wetenschappelijk Onderzoek (30446199)
- Stephan Swinnen
- Genevieve Albouy
HORIZON EUROPE Marie Sklodowska-Curie Actions (887955)
- Bradley R King
HORIZON EUROPE Marie Sklodowska-Curie Actions (703490)
- Judith Nicolas
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Randolph F Helfrich, University of Tübingen, Germany
Ethics
Human subjects: Young healthy volunteers were recruited by local advertisements to participate in the present study. Participants gave written informed consent before participating in this research protocol, approved by the local Ethics Committee (B322201525025) and conducted according to the declaration of Helsinki (2013). The participants received a monetary compensation for their time and effort.
Version history
- Preprint posted: September 3, 2021 (view preprint)
- Received: September 15, 2021
- Accepted: June 7, 2022
- Accepted Manuscript published: June 21, 2022 (version 1)
- Version of Record published: July 6, 2022 (version 2)
Copyright
© 2022, Nicolas et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,502
- Page views
-
- 330
- Downloads
-
- 5
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Neuroscience
Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β and misfolded tau proteins causing synaptic dysfunction, and progressive neurodegeneration and cognitive decline. Altered neural oscillations have been consistently demonstrated in AD. However, the trajectories of abnormal neural oscillations in AD progression and their relationship to neurodegeneration and cognitive decline are unknown. Here, we deployed robust event-based sequencing models (EBMs) to investigate the trajectories of long-range and local neural synchrony across AD stages, estimated from resting-state magnetoencephalography. The increases in neural synchrony in the delta-theta band and the decreases in the alpha and beta bands showed progressive changes throughout the stages of the EBM. Decreases in alpha and beta band synchrony preceded both neurodegeneration and cognitive decline, indicating that frequency-specific neuronal synchrony abnormalities are early manifestations of AD pathophysiology. The long-range synchrony effects were greater than the local synchrony, indicating a greater sensitivity of connectivity metrics involving multiple regions of the brain. These results demonstrate the evolution of functional neuronal deficits along the sequence of AD progression.
-
- Medicine
- Neuroscience
In recent years, there has been debate about the effectiveness of treatments from different fields, such as neurostimulation, neurofeedback, brain training, and pharmacotherapy. This debate has been fuelled by contradictory and nuanced experimental findings. Notably, the effectiveness of a given treatment is commonly evaluated by comparing the effect of the active treatment versus the placebo on human health and/or behaviour. However, this approach neglects the individual’s subjective experience of the type of treatment she or he received in establishing treatment efficacy. Here, we show that individual differences in subjective treatment - the thought of receiving the active or placebo condition during an experiment - can explain variability in outcomes better than the actual treatment. We analysed four independent datasets (N = 387 participants), including clinical patients and healthy adults from different age groups who were exposed to different neurostimulation treatments (transcranial magnetic stimulation: Studies 1 and 2; transcranial direct current stimulation: Studies 3 and 4). Our findings show that the inclusion of subjective treatment can provide a better model fit either alone or in interaction with objective treatment (defined as the condition to which participants are assigned in the experiment). These results demonstrate the significant contribution of subjective experience in explaining the variability of clinical, cognitive, and behavioural outcomes. We advocate for existing and future studies in clinical and non-clinical research to start accounting for participants’ subjective beliefs and their interplay with objective treatment when assessing the efficacy of treatments. This approach will be crucial in providing a more accurate estimation of the treatment effect and its source, allowing the development of effective and reproducible interventions.